In vitro studies of the interaction between cetirizine and H2 receptor antagonists using spectrophotometry and reversed-phase high-performance liquid chromatography

Medicinal Chemistry Research

Volumn 19, Issue 5, 2010, Pages 462-474

  Sultana, Najma ^a   Arayne, M Saeed ^a   Shamshad, Hina ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Cetirizine; H1 receptor antagonist; H2 receptor antagonist; HPLC; UV spectrophotometry

Indexed keywords

CETIRIZINE; CIMETIDINE; FAMOTIDINE; HILER; HISTAMINE H2 RECEPTOR ANTAGONIST; METHANOL; NULCER; RANITIDINE; ULCERAX; UNCLASSIFIED DRUG; WATER;

ARTICLE; BODY FLUID; CONTROLLED STUDY; DRUG DETERMINATION; DRUG POTENTIATION; DRUG STRUCTURE; FLOW RATE; IN VITRO STUDY; PH MEASUREMENT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ANALYSIS; TEMPERATURE MEASUREMENT; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION STUDY;

EID: 77953322404     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9204-x     Document Type: Article

References (27)

1. AY Abdel NA El-Sayed Al Salem 2005 Recent developments of derivative spectrophotometry and their analytical applications Anal Sci 21 595 10.2116/analsci.21.595 10.2116/analsci.21.595 (Pubitemid 40919102)
2. N Akhtar G Aziz M Ahmad AU Madni M Ashraf A Mahmood 2008 HPLC method for determination of famotidine in human plasma and its application in bioequivalence studies J Chem Soc Pak 30 567 570 1:CAS:528:DC%2BD1cXpslKrtr0%3D
3. MS Arayne N Sultana FA Siddiqui 2005 Determination and quantification of cetirizine HCl in dosage formulations by RP-HPLC Pak J Pharm Sci 18 7 11
4. 2-receptor antagonist J Chem Soc Pak 30 734 739 1:CAS:528:DC%2BD1cXhtF2gsbzI
5. 2-receptor antagonist interaction with cefixime J Chem Soc Pak 30 726 733 1:CAS:528:DC%2BD1cXhtF2gsbzP
6. Ashirua DA, Patel R, Basti AW (2007) Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine, and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers. GlaxoSmithKline, Harlow, pp 29-39
7. 2 histamine receptor antagonism Clin Otolaryngol 21 348 352 10.1111/j.1365-2273.1996.tb01085.x 10.1111/j.1365-2273. 1996.tb01085.x
8. S Braggio R Barnaby P Grossi M Cugola 1996 A strategy for validation of bioanalytical methods J Pharm Biomed Anal 14 375 388 10.1016/0731-7085(95)01644- 9 10.1016/0731-7085(95)01644-9 1:CAS:528:DyaK28Xjt1Shsro%3D 8729635 (Pubitemid 26160150)
9. 1-receptor antagonists hydroxyzine and cetirizine in rabbits Pharm Res 11 295 300 10.1023/A:1018971828065 10.1023/A:1018971828065 1:CAS:528:DyaK2cXhvVaktbs%3D 8165191 (Pubitemid 24076227)
10. LJ Cook S Shuster 1983 Lack of effect of cimetidine in chronicidiopathic urticaria Acta Derm Venereol 63 265 267 1:STN:280:DyaL3s3nvVCqtA%3D%3D 6192652
11. I-antagonists hydroxyzine and cetirizine in patients with chronic urticaria J Allergy Clin Immunol 95 685 693 10.1016/S0091-6749(95)70173- 7
12. European Pharmacoepia (2000) Her Majesty Stationary Office, pp 342-343
13. NM Gowekar VV Pande AV Kasture AR Tekade JG Chandorkar 2007 Spectrophotometric estimation of ambroxol and cetirizine hydrochloride from tablet dosage form Pak J Pharm Sci 20 250 251 1:STN:280:DC%2BD2szjt1Kmuw%3D%3D 17545112
14. 2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation J Allergy Clin Immunol 78 856 860 10.1016/0091-6749(86)90230-7 10.1016/0091-6749(86)90230- 7 1:CAS:528:DyaL2sXktlOlug%3D%3D 2878016 (Pubitemid 17194637)
15. S Hayashi S Hashimoto 1999 Antiinflammatory actions of new antihistamine Clin Exp Allergy 29 1593 1596 10.1046/j.1365-2222.1999.00703.x 10.1046/j.1365-2222.1999.00703.x 1:CAS:528:DC%2BD3cXjvFaksA%3D%3D 10594534 (Pubitemid 30012416)
16. 2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis Allergy 44 281 287 10.1111/j.1398-9995.1989.tb01070.x 10.1111/j.1398-9995.1989.tb01070.x 1:STN:280:DyaL1M3osFGqtQ%3D%3D 2567579
17. PH Howarth M Salagean D Dokic 2000 Allergic rhinitis: not purely a histamine-related disease Allergy 55 7 16 10.1034/j.1398-9995.2000.00802.x 10.1034/j.1398-9995.2000.00802.x 11291780
18. 2 receptor blockade on the inhibition of immediate cutaneous reactions Clin Pharm 3 60 64 1:STN:280:DyaL2c7jtV2mug%3D%3D 6141860
19. 2-receptor blocking agent Br J Clin Pharmacol 4 367 369 1:CAS:528:DyaE2sXks1egsr0%3D 901705
20. 2 antihistamines on histamine-induced bronchoconstriction and cutaneous wheal response in asthmatic patients J Allergy Clin Immunol 67 171 177 10.1016/0091-6749(81)90057-9 10.1016/0091-6749(81) 90057-9 1:STN:280:DyaL3M7hvVSgsA%3D%3D 6109741 (Pubitemid 11153796)
21. B Nilgun A Rebiay B Dilek D Peniz 1999 Comparison of acrivastine, loratadine, and cetirizine monotherapies, and coadministration with famotidine in the treatment of chronic idiopathic urticaria Turkiye Klinikleri Dermatol 9 206 209
22. 2 receptors in the human nose: rationale for topical use of combined antihistamine preparations J Allergy Clin Immunol 70 211 218 10.1016/0091-6749(82)90044-6 10.1016/0091-6749(82)90044-6 1:STN:280:DyaL383ms1Kqtg%3D%3D 6179976 (Pubitemid 12028769)
23. JA Smith LE Mansfield HS Nelson 1979 The effect of cimetidine on the immediate cutaneous response to allergens Ann Allergy 42 353 354 1:STN:280:DyaE1M3gslGjsA%3D%3D 453654
24. N Sultana MS Arayne H Shamshad 2008 Optimization of quantitative analysis of cetirizine in bulk drug, dosage formulations, and human serum using spectrophotometry J Chem Soc Pak 30 563 566 1:CAS:528:DC%2BD1cXpslKrtrw%3D
25. CT Taylor R Sodha B Warner JC Foreman 2005 Histamine receptors that influence blockage of the normal human nasal airway Br J Pharmacol 144 867 874 10.1038/sj.bjp.0706118 (Pubitemid 40516126)
26. L Virag C Szabo 2002 The therapeutic potential of poly (ADP-ribose) polymerase inhibitors Pharmacol Rev 54 375 429 10.1124/pr.54.3.375 10.1124/pr.54.3.375 1:CAS:528:DC%2BD38XotVSmsr8%3D 12223530
27. 2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season Acta Otolaryngol 116 91 96 10.3109/00016489609137720 10.3109/00016489609137720 1:STN:280: DyaK28vhslGltQ%3D%3D 8820358